Immunovia AB (FRA:1YR)
€ 0.0338 0.0013 (4%) Market Cap: 8.99 Mil Enterprise Value: 6.59 Mil PE Ratio: 0 PB Ratio: 2.83 GF Score: 42/100

Q1 2023 Immunovia AB (publ) Earnings Call Transcript

May 23, 2023 / 01:00PM GMT
Release Date Price: €0.105598 (-27.60%)
Operator

Ladies and gentlemen, welcome to the Immunovia Q1 Interim Report 2023 Conference Call. I am Sandra, the Chorus Call operator. (Operator Instructions) The conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Karin Almqvist, CFO. Please go ahead, madam.

Karin Almqvist Liwendahl;publ;CFO
Immunovia AB

()-

Thank you so much, and good morning and good afternoon to you all, and welcome to this conference call following Immunovia's first quarter results 2023. Present here in our office in Lund is Jeff Borcherding, CEO; and myself, Karin Almqvist, CFO of the company.

Before we get started, we have, as usual, some practical aspects. The presentation, as already announced, will be followed by a Q&A session, and the operator will guide us on how to pose questions. And in addition to that, last or not least, we do welcome questions after our presentation. Having closed the call today, you will find presentation and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot